As Dow Chemical Company (DOW) Share Value Rose, Shareholder Chemical Bank Trimmed by $5.46 Million Its Stake; Bristol (BMY) Position Has Lifted by Sol Capital Management Co

August 31, 2017 – By Richard Conner

Chemical Bank decreased its stake in Dow Chemical Company (DOW) by 5.8% based on its latest 2016Q4 regulatory filing with the SEC. Chemical Bank sold 95,761 shares as the company’s stock rose 0.05% with the market. The institutional investor held 1.56 million shares of the major chemicals company at the end of 2016Q4, valued at $89.06 million, down from 1.65M at the end of the previous reported quarter. Chemical Bank who had been investing in Dow Chemical Company for a number of months, seems to be less bullish one the $81.54 billion market cap company. The stock declined 0.95% or $0.63 reaching $66.02 per share. About 43.29 million shares traded or 862.00% up from the average. Dow Chemical Co (NYSE:DOW) has risen 20.72% since August 31, 2016 and is uptrending. It has outperformed by 4.02% the S&P500.

Christopher Pucillo increased its stake in Bristol (BMY) by 30.77% based on its latest 2016Q4 regulatory filing with the SEC. Sol Capital Management Co bought 5,182 shares as the company’s stock declined 1.04% while stock markets rallied. The hedge fund run by Christopher Pucillo held 22,022 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $1.29M, up from 16,840 at the end of the previous reported quarter. Sol Capital Management Co who had been investing in Bristol for a number of months, seems to be bullish on the $99.18B market cap company. The stock declined 0.48% or $0.29 reaching $60.19 on the news. About 9.71M shares traded or 51.25% up from the average. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since August 31, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

Investors sentiment decreased to 0.97 in Q4 2016. Its down 0.16, from 1.13 in 2016Q3. It fall, as 86 investors sold BMY shares while 529 reduced holdings. 126 funds opened positions while 468 raised stakes. 1.14 billion shares or 1.92% more from 1.12 billion shares in 2016Q3 were reported. Gillespie Robinson Grimm owns 6,046 shares. Of Virginia Va invested 0.22% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Goelzer Incorporated invested in 0.31% or 40,667 shares. Baxter Bros Inc reported 18,798 shares. Pax World Mgmt Limited Liability Company has invested 0.04% in Bristol-Myers Squibb Co (NYSE:BMY). Sonata Cap holds 0.23% or 5,035 shares in its portfolio. New York-based Sessa Capital Im Ltd Partnership has invested 2.2% in Bristol-Myers Squibb Co (NYSE:BMY). Sit Inv Assocs reported 8,863 shares. Epoch Partners invested in 3,500 shares. Kistler has invested 0.3% in Bristol-Myers Squibb Co (NYSE:BMY). Stock Yards National Bank And Tru owns 61,108 shares. Plante Moran Advsr Llc holds 0.1% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY) for 2,818 shares. West Chester Advisors Inc stated it has 15,142 shares. Beese Fulmer Invest holds 53,137 shares or 0.8% of its portfolio. Howland Capital Mgmt Limited Liability Company accumulated 42,368 shares or 0.23% of the stock.

Sol Capital Management Co, which manages about $1.79 billion and $332.67M US Long portfolio, decreased its stake in Blackstone Group Lp (NYSE:BX) by 44,935 shares to 80,175 shares, valued at $2.17 million in 2016Q4, according to the filing.

Since March 3, 2017, it had 0 insider buys, and 5 insider sales for $5.32 million activity. 15,000 shares were sold by Schmukler Louis S, worth $851,220. 8,096 shares were sold by Caldarella Joseph C, worth $463,779 on Wednesday, March 15. The insider LEUNG SANDRA sold 92,405 shares worth $5.27 million.

More notable recent Bristol-Myers Squibb Co (NYSE:BMY) news were published by: Seekingalpha.com which released: “What About A Bristol-Myers Squibb Takeover By Pfizer?” on August 31, 2017, also Seekingalpha.com with their article: “Bristol-Myers – Adding To The Pipeline With IFM” published on August 07, 2017, Law360.com published: “Bristol-Myers Squibb: Clear Direction For State Courts” on August 31, 2017. More interesting news about Bristol-Myers Squibb Co (NYSE:BMY) were released by: Fool.com and their article: “What’s Next for Bristol-Myers Squibb After Its Opdivo Setback?” published on August 22, 2017 as well as Seekingalpha.com‘s news article titled: “Bristol-Myers Squibb Combination Treatment Not At The End Of The Crossroad” with publication date: August 16, 2017.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 52 analyst reports since July 28, 2015 according to SRatingsIntel. On Monday, May 9 the stock rating was maintained by Credit Suisse with “Outperform”. Cowen & Co maintained it with “Hold” rating and $6500 target in Monday, August 14 report. The firm has “Underweight” rating by Piper Jaffray given on Monday, August 24. As per Thursday, July 14, the company rating was maintained by Jefferies. BMO Capital Markets maintained Bristol-Myers Squibb Co (NYSE:BMY) on Sunday, July 23 with “Sell” rating. The firm earned “Sell” rating on Wednesday, August 16 by BMO Capital Markets. The firm has “Buy” rating by UBS given on Friday, April 29. On Wednesday, April 26 the stock rating was initiated by Robert W. Baird with “Outperform”. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned “Market Perform” rating by BMO Capital Markets on Wednesday, April 5. The stock has “Equal Weight” rating by Barclays Capital on Friday, April 29.

Investors sentiment increased to 1.52 in 2016 Q4. Its up 0.18, from 1.34 in 2016Q3. It is positive, as 53 investors sold DOW shares while 333 reduced holdings. 128 funds opened positions while 459 raised stakes. 790.77 million shares or 7.17% more from 737.86 million shares in 2016Q3 were reported. United Services Automobile Association has 1.75M shares for 0.33% of their portfolio. Cap Int Incorporated Ca holds 0.01% or 1,700 shares in its portfolio. Stralem & has invested 3.3% in Dow Chemical Co (NYSE:DOW). Florida-based Fidelity National has invested 5.09% in Dow Chemical Co (NYSE:DOW). Amalgamated National Bank has invested 0.19% in Dow Chemical Co (NYSE:DOW). Moreover, Raymond James Tru Na has 0.22% invested in Dow Chemical Co (NYSE:DOW). Family Corp stated it has 109,538 shares. Voya Mngmt Ltd Liability Co holds 7.04 million shares. South Texas Money Management has invested 0.01% in Dow Chemical Co (NYSE:DOW). Rock Point Advisors Ltd Liability has 5,040 shares for 0.15% of their portfolio. Psagot Investment House owns 9,300 shares. Bartlett & Limited owns 24,420 shares for 0.07% of their portfolio. Van Strum & Towne owns 3,645 shares. 3,150 are held by Sanctuary Wealth Advsr. Hennessy has invested 0.08% in Dow Chemical Co (NYSE:DOW).

More notable recent Dow Chemical Co (NYSE:DOW) news were published by: Detroitnews.com which released: “Dow Chemical, DuPont to close merger August 31” on August 05, 2017, also Nasdaq.com with their article: “Dow Chemical Co Buys SPDR S&P 500, Sells SPDR Select Sector Fund – Technology …” published on August 24, 2017, Mlive.com published: “Dow employees in Texas ‘accounted for and safe’ in Hurricane Harvey aftermath” on August 31, 2017. More interesting news about Dow Chemical Co (NYSE:DOW) were released by: Seekingalpha.com and their article: “Dow-DuPont: The Activist Horsemen” published on August 07, 2017 as well as Reuters.com‘s news article titled: “Dow Chemical plans to boost stake in Sadara JV to 50 percent” with publication date: August 28, 2017.

Among 16 analysts covering The Dow Chemical Company (NYSE:DOW), 10 have Buy rating, 1 Sell and 5 Hold. Therefore 63% are positive. The Dow Chemical Company had 47 analyst reports since August 20, 2015 according to SRatingsIntel. Citigroup upgraded it to “Buy” rating and $59 target in Monday, October 3 report. The stock of Dow Chemical Co (NYSE:DOW) earned “Hold” rating by S&P Research on Friday, October 23. The rating was maintained by Barclays Capital on Monday, May 2 with “Equal Weight”. RBC Capital Markets maintained the shares of DOW in report on Friday, April 29 with “Outperform” rating. On Friday, August 14 the stock rating was downgraded by Zacks to “Buy”. On Friday, October 28 the stock rating was maintained by RBC Capital Markets with “Top Pick”. On Monday, October 10 the stock rating was upgraded by UBS to “Buy”. On Wednesday, February 3 the stock rating was upgraded by RBC Capital Markets to “Top Pick”. The company was maintained on Monday, December 14 by Jefferies. The rating was maintained by Piper Jaffray on Friday, September 4 with “Hold”.